Documentos de Académico
Documentos de Profesional
Documentos de Cultura
10 Therapeutics Development
11 Pipeline Products for Ischemic Stroke - Overview
11 Pipeline Products for Ischemic Stroke - Comparative Analysis 12 Ischemic Stroke - Therapeutics under
Development by Companies
13 Ischemic Stroke - Therapeutics under Investigation by Universities/Institutes 18 Ischemic Stroke - Pipeline
Products Glance
19 Late Stage Products
19 Clinical Stage Products
20 Early Stage Products
21 Ischemic Stroke - Products under Development by Companies
22 Ischemic Stroke - Products under Investigation by Universities/Institutes
27 Ischemic Stroke - Companies Involved in Therapeutics Development
28 AB Science SA
28 Acticor Biotech
29 advanceCor GmbH
30 Angion Biomedica Corp.
31 AstraZeneca Plc
32 Athersys, Inc.
33 biOasis Technologies Inc.
34 Biogen, Inc.
35 BioTime, Inc.
36 D-Pharm Ltd. 37 Daiichi Sankyo Company, Limited 38 DiaMedica Inc.
39 Digna Biotech, S.L. 40 Genervon Biopharmaceuticals, LLC
41 Glialogix, Inc.
42 Glucox Biotech AB
43 Grifols, S.A.
44 Huons Co., Ltd.
45 International Stem Cell Corporation
46 JN-International Medical Corporation 47 Laboratoires Pierre Fabre SA
48 Lumosa Therapeutics Co., Ltd.
49 MediaPharma s.r.l.
50 Mitsubishi Tanabe Pharma Corporation
51 Neuralstem, Inc.
52 Neurotec Pharma SL
53 NeuroVive Pharmaceutical AB
54 NoNO, Inc.
55 Panacea Pharmaceuticals, Inc.
56 Pharmicell Co., Ltd.
57 PhytoHealth Corporation
58 Remedy Pharmaceuticals, Inc.
59 ReNeuron Group Plc
60 SanBio, Inc.
61 Saneron CCEL Therapeutics, Inc.
62 Simcere Pharmaceutical Group
63 Stemedica Cell Technologies, Inc.
64 SynZyme Technologies, LLC
65 The International Biotechnology Center (IBC) Generium
66 TikoMed AB
67 vasopharm GmbH 68 Vicore Pharma AB
69 Virogenomics, Inc.
70 Ischemic Stroke - Therapeutics Assessment
71 Assessment by Monotherapy Products
71 Assessment by Target
72 Assessment by Mechanism of Action
76 Assessment by Route of Administration
79 Assessment by Molecule Type
81 Drug Profiles
83 3K3A-APC - Drug Profile
83 ACT-017 - Drug Profile
85 alteplase biosimilar - Drug Profile
86 BB-3 - Drug Profile
87 BSc-2118 - Drug Profile
90 C-21 - Drug Profile
91 Cerecellgram-Stroke - Drug Profile
93 CNB-001 - Drug Profile
94 DB-017 - Drug Profile
96 DM-199 - Drug Profile
97 Drugs to Inhibit Sir2 Protein for Ischemic Stroke and Myocardial Infarction - Drug Profile
98 DS-1040 - Drug Profile
99 GLX-1112 - Drug Profile
100 glyburide - Drug Profile
101 GM-602 - Drug Profile
103 GXNPC-1 - Drug Profile
104 HBN-1 - Drug Profile
105 HU-010 - Drug Profile
106 Human Plasmin - Drug Profile
107 Human Umbilical Cord Blood Cell Therapy for Neurological and Cardiovascular Diseases - Drug Profile
109 ISC-hpNSC - Drug Profile
112 levomilnacipran hydrochloride ER - Drug Profile
114 LT-3001 - Drug Profile
116 Lysimab - Drug Profile
117 masitinib - Drug Profile
118 Memantine Nitrone - Drug Profile
123 Mesenchymal Stem Cells - Drug Profile 124 MP124 - Drug Profile 126 MPHE-001A - Drug Profile
127 MTfp-siRNA - Drug Profile 128 MultiStem - Drug Profile
129 NA-1 - Drug Profile
133 natalizumab - Drug Profile
135 NSI-566 - Drug Profile
137 NTKC-005 - Drug Profile
139 NVP-014 - Drug Profile
140 NVX-208 - Drug Profile
141 PAN-811 - Drug Profile
142 Peptide to Agonize GHSR-1a for Sepsis, Acute Radiation Syndrome and Acute Ischemic Stroke - Drug Profile
144 PHN-014 - Drug Profile
146 Pinocembrin - Drug Profile
147 Polyglactin
370 for Ischemic Stroke - Drug Profile
148 PR-15 - Drug Profile
149 prasugrel hydrochloride - Drug Profile
Contact Us:
iData Insights
Tel: 1-866-237-2965
Web: http://www.idatainsights.com
Email: info@idatainsights.com